Our Platform Ecosystem

Our work operates through an integrated scientific ecosystem designed to move natural product data from biological exploration to software-driven discovery and real-world antimicrobial solutions.

Each entity plays a distinct role in data generation, computational modeling, and commercialization of plant-derived antimicrobial technologies.

KANISZEWSKI LABORATORIES, LLC

Natural Product Data Generation & Scientific Infrastructure

  • Kaniszewski Laboratories serves as the core research and data generation platform responsible for building a proprietary library of 1,000+ plant species. This wet lab infrastructure is dedicated to the extraction, characterization, and biochemical profiling of natural products, generating high-quality datasets required to power AI-driven discovery.

  • The laboratory integrates expertise in plant pathology, natural-product chemistry, structural biology, and advanced analytical workflows to produce structured biological data at scale. These datasets form the foundation for modeling bioactive compound space, identifying functional chemical classes, and enabling predictive discovery.

  • In addition to research activities, Kaniszewski Laboratories provides domain expert consulting in biological systems, antimicrobial discovery, and AI-assisted scientific evaluation. This includes AI model assessment, experimental design, and technical consulting at the intersection of artificial intelligence and life sciences.

  • Kaniszewski Laboratories functions as the foundational data layer supporting software development and commercialization across the broader ecosystem, including KR-NATURAL PRODUCTS, MAACKII BIO, and CANNA MAACKII.

KR-NATURAL PRODUCTS
AI-Driven Natural Product Discovery Software

  • KR-NATURAL PRODUCTS is a computational platform focused on mapping bioactive chemical space, predicting biosynthetic pathways, and modeling synergistic interactions among secondary metabolites. The platform is designed to transform raw biological data into actionable insights for compound discovery and development.

  • Applications include investment-grade technical evaluation of natural product assets, identification of novel antimicrobial candidates, and computational design of compound analogs for biotechnology, agriculture, and pharmaceutical use.

MAACKII BIO
Platform Commercialization

  • MAACKII BIO advances the commercialization of a patented tree-derived antimicrobial platform. This platform demonstrates broad-spectrum antimicrobial activity, including inhibition of fungal and oomycete pathogens as well as Candida species, and is being developed across agriculture, human health, wildlife protection, food safety, and environmental systems.

  • MAACKII BIO serves as a primary validation engine for software-guided discovery, translating computational predictions into real-world antimicrobial solutions across approximately 32 addressable industry verticals.

CANNA MAACKII
Cannabis & Hemp Pathogen Solutions

  • CANNA MAACKII applies software-guided antimicrobial strategies to cannabis and hemp production systems. The focus is on controlling microbial contamination and pathogen pressure in cultivation and processing environments.

  • Research includes targeted inhibition of key pathogens such as Botrytis, Fusarium, and Aspergillus, along with broader microbial risk mitigation aligned with regulatory and safety requirements.

  • Together, these organizations form a vertically integrated biotechnology platform spanning data generation, AI-driven discovery, and commercialization, enabling scalable development of plant-derived antimicrobial technologies across multiple biological and industrial domains.

Learn more